The Economics of Cancer Care

June 1 from 11:00 AM-5:00 PM and June 2 from 7:30 AM-11:00 AM

Seminar Description

Oncology professionals are practicing in an increasingly complex economic landscape, with pressures from several different areas. There is much discussion regarding treatment costs, impacting both practice sustainability and patient financial burden, as well as how to reward therapeutic innovation while managing development costs. Innovative reimbursement, coverage, and treatment models provide lessons learned and new best practices, and the base of data in this area is rapidly expanding. All of this coupled with clinical trial costs and trends in overall cancer treatment spending have resulted in a wealth of information to examine and assimilate into individual research and practice decisions. This seminar will provide learners with relevant information regarding all of these topics so they can make better-informed decisions in their relations with patients, payers, and others.

Seminar Committee

View Seminar Committee Disclosures

Rena M. Conti, PhD​ (Chair)​
University of Chicago

John Vernon Cox, DO, FACP, FASCO, MBA
Parkland Health System/UTSW

Elad Sharon, MD, MPH
National Cancer Institute

Robin Yabroff, PhD
US Department of Health and Human Services

 

Seminar Agenda

Day 1: Thursday, June 1, 2017: 12:30 PM – 5:00 PM

12:30 PM – 1:00 PM Lunch
1:00 PM – 2:50 PM

Session 1: Financial Toxicity and Cost

Robin Yabroff, PhD - Co-Chair
US Department of Health and Human Services

 

Rena Conti, PhD - Co-Chair
University of Chicago
Defining "Financial Toxicity" and Review

 

Lauren Nicholas, PhD
Johns Hopkins Bloomberg School of Public Health
Out-of-Pocket Spending and Financial Burden Among Medicare Beneficiaries With Cancer

 

Veena Shankaran, MD, MS
University of Washington
SWOG Study

 

TBD
Adherence Issues

 

TBD
A Patient Advocacy Perspective: Efforts and Potential Solutions to Toxicity

 

Question and Answer Panel Discussion

2:50 PM – 3:10 PM Break
3:10 PM – 5:00 PM

Session 2: Big Data in Oncology

Elad Sharon, MD, MPH - Chair
National Cancer Institute

 

TBD
Presentation topic currently being finalized

 

Debra Patt, MD, MPH, MBA
McKesson Specialty Health - US Oncology Network
US Oncology Quantitative Analyses

 

Louis Fiore, MD, MPH
VA Boston Healthcare System
The VA and Big Data

 

TBD
ASCO's CancerLinQ

 

Sean Khozin, MD, MPH
US Food and Drug Administration
Information Exchange and Data Transformation (INFORMED)

 

Question and Answer Panel Discussion

 

 

Day 2: Friday, June 2, 2017: 7:00 AM – 11:00 AM

7:00 AM – 7:30 AM Breakfast
7:30 AM – 9:10 AM

Session 3: What Can We Learn from the International Experience?

Robin Yabroff, PhD - Co-Chair
US Department of Health and Human Services

 

TBD - Co-Chair

 

Speakers and Presentations are Currently Being Finalized

9:10 AM – 9:30 AM Break
9:30 AM – 11:00 AM

Session 4: Cancer Care Policy Forum: Federal and State Perspectives

Rena Conti, PhD - Moderator
University of Chicago

 

Panelists are Currently Being Finalized